Return to face-to-face classes, without vaccination

Many parents become distressed every time the subject of returning to face-to-face classes is raised. It is no wonder, the pandemic is still active and for children and adolescents there is no vaccine yet.

Although they have the right to be immunized whether or not they are a low-risk population, scientifically there are no studies; The same path that allowed obtaining inoculation for adults has not been followed.

In a webinar of Weaving Networks in Childhood, directed by Juan Martín Pérez, pediatric cardiologist Paola Vidal Rojo explained that children have a different immunity from adults. Specific studies are needed to determine the safety and efficacy of a vaccine.

Children and adolescents have been considered the least vulnerable in this health crisis and are seen more as vectors of contagion. However, there are cases of minors who have been serious for covid-19 and even deaths.

The latter are related to comorbidities, they were Down patients, with obesity, childhood diabetes and asthma.

Norberto Liwski, former vice president of the UN Committee on the Rights of the Child, stressed that children are not exempt from acquiring the disease and being asymptomatic carriers.

He commented that clinical trials have started in various parts of the world and there will soon be vaccines for the 12 to 16-year-old age group.

Meanwhile, he warns, it is essential to be immunized against other diseases, as the scheme has been neglected for fear of contagion.

Mexico is the number one country in childhood obesity, one of the most important comorbidities to produce complications from coronavirus.

With home confinement, anxiety has skyrocketed and this worsens eating problems, turning into a vicious circle.

Moderna began late-stage trials to demonstrate the efficacy of its vaccine in children under 11 years of age in the United States and Canada.

The company, which has already received emergency authorization to vaccinate those over 18 years of age, has begun to inoculate children between six months and 11 years of age to be able to demonstrate the response in younger people.

Mexico began negotiations for the country to have access to the first trials of vaccines for minors, a process that is expected to advance soon. _

– .